TMPRSS2, a novel host-directed drug target against SARS-CoV-2

Ngā tūemi rite

• Proteolytic activation of Zaire ebolavirus and SARS-CoV-2 class I membrane fusion proteins by different host cell proteases
  mā: Dorothea, Bestle
  I whakaputaina: (2022)
• The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
  mā: Schieffer, Elisabeth, me ētahi atu.
  I whakaputaina: (2023)
• Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2
  mā: Grote, Karsten, me ētahi atu.
  I whakaputaina: (2024)
• Inhibition of Rab1B Impairs Trafficking and Maturation of SARS-CoV-2 Spike Protein
  mā: Veeck, Christopher, me ētahi atu.
  I whakaputaina: (2023)
• Multiplexed electrochemical liposomes applied to the detection of nucleic acids for Influenza A, Influenza B and SARS-CoV-2
  mā: Gerstl, Florian, me ētahi atu.
  I whakaputaina: (2024)